The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024.
In total, 8 708 strains were included. Escherichia coli had a higher resistance to carbapenems (p < 0.05) in the 0-17 years group and Klebsiella pneumoniae (p = 0.017), Pseudomonas aeruginosa, and Acinetobacter baumannii (p < 0.05) in the 18-59 years group. P. aeruginosa had higher resistance to ceftazidime-avibactam, ceftolozane-tazobactam, cefepime, and imipenem (p < 0.05) in the 18-59 years group. K. pneumoniae had the highest resistance to carbapenems (p < 0.05) and cefepime (p < 0.001) in clinical isolates recovered from blood. For P. aeruginosa, the highest resistance to cefepime (p = 0.012) and ceftazidime (p < 0.018) was seen in isolates from urine. For Staphylococcus aureus, a higher resistance was observed for cefoxitin in lower respiratory tract specimens (p < 0.05). E. coli had the highest resistance to carbapenems (p < 0.01), and P. aeruginosa for ceftazidime (p = 0.005), cefepime (p = 0.003), piperacillin-tazobactam (p = <0.01), IPM (p = 0.006), and meropenem (p = <0.01) in clinical isolates recovered from patients in the intensive care unit (ICU). For K. pneumoniae, the highest resistance to ertapenem was observed in clinical isolates from the ICU area (p < 0.035). Finally, 67.9% of A. baumannii and 53.8% of E. coli strains were Multidrug-resistant. Candida albicans isolated from blood had susceptibility to caspofungin 100% and 90.2% for voriconazole. Regarding E. coli non-susceptible to meropenem, 16 (59.2%) were carriers of blaNDM, and the blaKPC gene was detected in 2 (40%) strains of K. pneumoniae. In conclusion, carbapenem resistance was higher for E. coli in the 0-17 years group and for K. pneumoniae, P. aeruginosa, and A. baumannii in the 18-59 years group. K. pneumoniae has the highest resistance to carbapenems in blood isolates and the ICU area. E. coli and P. aeruginosa had the highest carbapenem resistance in the intensive care unit. A high multidrug resistance was observed for A. baumannii and E. coli strains. A high susceptibility to caspofungin and voriconazole was observed for Candida albicans collected from blood.
Authors
- Dora Elia Rodríguez-Balderas
- Sandra Quintana-Ponce (ORCID: https://orcid.org/0000-0001-7184-994X)
- Patricia Rodríguez‐Zulueta (ORCID: https://orcid.org/0000-0001-5094-7890)
- Elvira Garza‐González (ORCID: https://orcid.org/0000-0001-5831-9661)
- María del Rocío López-Álvarez
- José Manuel Feliciano-Guzmán (ORCID: https://orcid.org/0000-0002-5141-6044)
- Enrique Bolado-Martínez (ORCID: https://orcid.org/0000-0002-3320-0872)
- Luís Javier Quintanilla-Cazares
- Nicolás Rogelio Eric Barlandas Rendón (ORCID: https://orcid.org/0000-0003-0196-8868)
- María del Rosario Vázquez-Larios
- Claudia Adriana Colín‐Castro (ORCID: https://orcid.org/0000-0001-7280-2086)
- Laura Isabel López-Moreno
- Maricruz Gutiérrez-Brito
- Aldo Rafael Silva-Gamiño (ORCID: https://orcid.org/0009-0001-0108-9030)
- Rafael Franco‐Cendejas (ORCID: https://orcid.org/0000-0003-1574-1138)
- Bernardo Alfonso Martínez-Guerra (ORCID: https://orcid.org/0000-0002-5191-2179)
- Cecilia Padilla-Ibarra
- César Adame-Álvarez
- María Asunción Santiago-Calderón
- Elena Victoria Choy-Chang
- Guadalupe Soledad Huirache-Villalobos
- Consuelo Velázquez-Acosta (ORCID: https://orcid.org/0000-0001-9962-1306)
- Mario Galindo-Méndez (ORCID: https://orcid.org/0000-0002-6485-3390)
- Carlos Antonio Couoh-May
- Laura Karina Avilés-Benítez (ORCID: https://orcid.org/0000-0002-7402-2398)
- Fabián Rojas‐Larios (ORCID: https://orcid.org/0000-0003-1744-9173)
- Luis Esaú López-Jácome (ORCID: https://orcid.org/0000-0001-7387-0937)
- Talia Pérez-Vicelis
- María Isabel Rodríguez‐García (ORCID: https://orcid.org/0000-0002-7664-3235)
- Guillermo Jacobo‐Baca (ORCID: https://orcid.org/0000-0003-3271-8781)
- María Fernanda González-Lara (ORCID: https://orcid.org/0000-0003-0292-3442)
- Christian Daniel Mireles-Dávalos
- Juan Pablo Mena-Ramírez (ORCID: https://orcid.org/0000-0002-8933-3228)
- Bertha Alicia Pérez-Vega
- Luis Raúl Rivera-Garay
- María Bertha Ballesteros-Silva
- Norberta Vianey Navarro-Vargas
- Juan de Dios Castañeda-Duarte
- Antonio López‐Vázquez
- Adolfo Gómez-Quiroz
- Thalia Rosado-Espinosa
- Pablo Hernan Sandoval-Villaseñor (ORCID: https://orcid.org/0009-0009-7359-1802)
- Sandra María Suárez-Moreno
- Elda Gabriela Vázquez-Narvaez
- Melissa Garibaldi-Rojas
- Víctor Hugo Peralta-Peñúñuri
- Ángela Cecilia Valtierra
- Paulina Fabiola González-Melgoza
- Luis Gerardo Medina-Navarro
- Ibis De-la-Cruz-Hernández
- Ernesto Mario Aguilar-Trejo
Institutions
- Autonomous University of Chihuahua (MX)
- University of Quintana Roo (MX)
- Universidad Autónoma de Nuevo León (MX)
- Instituto Tecnológico de Oaxaca (MX)
- Universidad de Guadalajara (MX)
- Hospital General de México (MX)
- Universidad Autónoma de Guerrero (MX)
- Universidad de Sonora (MX)
- Universidad de Hermosillo (MX)
- Secretaría de Salud de Jalisco (MX)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Universidad de Morelia (MX)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- Instituto Tecnológico de Apizaco (MX)
- Centro Universitario México Valle (MX)
- Hospital General Dr. Manuel Gea Gonzalez (MX)
- Hospital Civil de Guadalajara (MX)
- Hospital General De Zona (MX)
- Instituto Nacional de Rehabilitación (MX)
- Instituto Universitario de Oaxaca (MX)
- Universidad Kino (MX)
- Hospital de Especialidades (MX)
- Universidad de León (MX)
- Hospital Regional de Alta Especialidad del Bajío (MX)
- El Colegio de Sonora (MX)
- Hospital del Niño (PA)
- Instituto Nacional de Cancerología (MX)
- Siloam Eye Hospital (KR)
- Instituto Nacional de Cardiología (MX)
- Universidad Mesoamericana de San Agustín (MX)
- Guhua Hospital (CN)
- Centro Universitario de Chihuahua (MX)
- Universidad Nacional Autónoma de México (MX)
- Universidad de Colima (MX)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1371/journal.pone.0319441
- Citations
- 9
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 5.32
Funders
- Instituto Científico Pfizer